Market Research Report
Asia-Pacific Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
|Asia-Pacific Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027|
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 160 Pages
Delivery time: 3-5 business days
Asia- Pacific alopecia treatment (hair loss) market is projected to register a CAGR of 7.6% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Asia-Pacific Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Traction Alopecia, Ciatricial Alopecia, Others), Treatment (Localized Therapies, Medical Devices, Systemic Therapies, Herbal Treatment), Gender (Male, Female), Form (Topical, Oral, Parenteral), End User (Dermatology Centers, Hospitals, Home Healthcare), Distribution Channel (Pharmacies, Retail Sales, Direct Tender), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2027
Rise in prevalence of alopecia conditions
Increase in geriatric population
Gerolymatos International SA
Taisho Pharmaceutical Holdings Co., Ltd.
Vita-Cos-Med Klett-Loch GmbH
Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceuticals Industries Ltd.)
Par Pharmaceutical (A Subsidiary of Endo International plc)
Dr. Reddy's Laboratories Ltd.
Johnson & Johnson Services, Inc
Sun Pharmaceutical Industries Ltd.
Perrigo Company plc
Viviscal Limited (A Subsidiary of Church & Dwight Co.)
Dr. Kurt Wolff GmbH & Co. KG
Labo International S.r.l.
WON TECH Co., Ltd.